Crossmark

Renal-tubular-mitochondrial sequentially targeted nanoagent breaks the vicious cycle of oxidative stress and mtDNA-driven inflammation in acute kidney injury therapy

Crossref DOI link: https://doi.org/10.1186/s12951-026-04049-2

Published Online: 2026-01-24

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Zhang, Chenli

Tan, Ling

Yang, Pengfei

Huang, Lili

Xiang, Zeli

Zhao, Lingshan

Zhang, Ling

Deng, Jun

Liao, Xiaohui
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (82222039)
License Information

Text and Data Mining valid from 2026-01-24

Version of Record valid from 2026-02-17
More Information

Article History

Received: 18 October 2025

Accepted: 8 January 2026

First Online: 24 January 2026

Declarations

: All animal procedures were approved by the Chongqing Medical University Animal Care and Use Committee (approval no.: IACUC-SAHCQMU-2023-0061).

: All authors agree for publication.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below